CHANDRA SHEKAR RAO SIMHADRI's Insider Trades & SAST Disclosures
CHANDRA SHEKAR RAO SIMHADRI's most recent trade in Vanta Bioscience Ltd. was a Acquisition of 5,250 Equity Shares done at an average price of Rs. 98.6 . Disclosure was reported to the exchange on June 25, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for CHANDRA SHEKAR RAO SIMHADRI in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanta Bioscience | CHANDRA SHEKAR RAO SIMHADRI | Promoter | Acquisition | 25 Jun 2022 | 5,250 | 115,000 (1.82%) | 0.08% | 98.6 | 517,875 | 21 Jun 2022 21 Jun 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Vanta Bioscience | CHANDRA SHEKAR RAO SIMHADRI | Promoter | Acquisition | 21 Jun 2022 | 9,750 | 109,750 (1.74%) | 0.15% | 92.6 | 902,843 | 16 Jun 2022 20 Jun 2022 |
Insider Trading | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.